Cisplatin-modified de Gramont in second-line therapy for pancreatic adenocarcinoma.
Ky V, Hav M, Berrevoet F, Troisi RI, Ferdinande L, Monsaert E, Vanderstraeten E, De Bosschere K, Van Damme N, Laurent S, Geboes K.
Ky V, et al. Among authors: laurent s.
Pancreas. 2013 Oct;42(7):1138-42. doi: 10.1097/MPA.0b013e31829a80b7.
Pancreas. 2013.
PMID: 24048454